Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Lion Group Holding Ltd Announces $10 Million Private Placement for the acquisition of Bitcoin (BTC)
-
Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics
-
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
-
Senti Bio reports Q3 financial results, confirms ASH data presentation
-
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual
-
Chardan Capital Markets Downgrades Korro Bio Inc. (KRRO) to Neutral
-
Corvex to merge with Movano in all-stock deal creating AI infrastructure firm
-
CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
-
Monopar Therapeutics (MNPR) PT Raised to $100 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral
-
Alps Announces Closing of Business Combination with Globalink Investment Inc.
-
Chardan Capital Markets Starts Kodiak AI (KDK) at Buy
-
Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral
-
Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral
-
Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
-
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
-
Avidity Biosciences to Participate in Upcoming Investor Conference
-
Chardan Capital Markets Starts Opus Genetics (IRD) at Buy
-
Beacon Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference
-
REGENXBIO to Participate in Upcoming Investor Conferences
-
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
-
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
-
Opus Genetics to Participate in Chardan's 9th Annual Genetic Medicines Conference
-
Affinia Therapeutics to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
-
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
ProQR to Participate in Upcoming Investor Conferences in October 2025
-
ARTHEx Biotech to Participate in Upcoming Investor and Industry Events
-
Prime Medicine to Participate in Upcoming Investor Conferences
-
Editas Medicine to present EDIT-401 data at gene therapy congress
-
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
-
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
-
Ocugen to Present at Industry and Investor Conferences in October 2025
-
ZOOZ purchases 525 bitcoin for $60 million following shareholder approval
-
Zooz Completes $60 Million Bitcoin Purchase
-
ZOOZ completes $60 million bitcoin purchase after shareholder approval
-
ZOOZ Completes Initial Purchase of ₿525 Valued at $60 Million, Becomes the First Dual-listed (Nasdaq and TASE) Company to Launch a Bitcoin Treasury Reserve Strategy
-
Sonim Technologies enters equity facility agreement with Chardan
-
Chardan Capital Markets Starts Reviva Pharmaceuticals (RVPH) at Buy, PT $2
-
Chardan Capital Markets Starts Alto Neuroscience (ANRO) at Buy, PT $15
-
Chardan Capital Markets Starts Immunic Inc. (IMUX) at Buy, PT $3
-
AlphaTON Capital raises $71 million, acquires $30 million in TON tokens
-
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
-
Kodiak completes SPAC merger, to begin trading on NASDAQ as KDK
-
Kodiak Completes Business Combination with Ares Acquisition Corporation II to Accelerate Journey as a Leading AI-Powered Autonomous Vehicle Technology Company
-
ZOOZ Shareholders Approve Previously Announced $180 Million Private Placement and Bitcoin Treasury Reserve Strategy, Along with All Related Proposals
-
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences

